Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tohgi

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Neuroscience Letters|February 5, 1993
Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptomsH Tohgi, T Abe, S Takahashi, et al.
Neuroscience Letters|August 26, 1999
Changes with aging and ischemia in nicotinic acetylcholine receptor subunit alpha7 mRNA expression in postmortem human frontal cortex and putamenK Utsugisawa, Y Nagane, H Tohgi, et al.
Thrombosis Research|December 12, 2001
Ischemic stroke among inpatients with preceding inflammatory responseH Tohgi, H Takahashi, K Tamura, et al.
Neuroscience Letters|August 14, 1990
Effect of a synthetic norepinephrine precursor, L-threo-3,4- dihydroxyphenylserine on the total norepinephrine concentration in the cerebrospinal fluid of parkinsonian patientsH Tohgi, T Abe, S Takahashi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 3, 1999
The cerebrospinal fluid oxidized NO metabolites, nitrite and nitrate, in Alzheimer's disease and vascular dementia of Binswanger type and multiple small infarct typeH Tohgi, T Abe, K Yamazaki, et al.
Neuroscience Letters|June 16, 1995
Effects of the catechol-O-methyltransferase inhibitor tolcapone in Parkinson's disease: correlations between concentrations of dopaminergic substances in the plasma and cerebrospinal fluid and clinical improvementH Tohgi, T Abe, K Yamazaki, et al.
European Neurology|January 1, 1991
The risk of cerebral infarction in non-valvular atrial fibrillation: effects of age, hypertension and antihypertensive treatmentH Tohgi, T Tajima, T Konno, et al.
Muscle & Nerve|February 1, 1997
Effects of CTG trinucleotide repeat expansion in leukocytes on quantitative muscle histopathology in myotonic dystrophyH Tohgi, K Utsugisawa, A Kawamorita, et al.
Neuroscience Letters|March 17, 1999
Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosisH Tohgi, T Abe, K Yamazaki, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1985
[Vascular dementia--pathology and etiology]H Tohgi, K Sasaki, K Chiba, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Neuroscience Letters|February 5, 1993
Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptomsH Tohgi, T Abe, S Takahashi, et al.
Neuroscience Letters|August 26, 1999
Changes with aging and ischemia in nicotinic acetylcholine receptor subunit alpha7 mRNA expression in postmortem human frontal cortex and putamenK Utsugisawa, Y Nagane, H Tohgi, et al.
Thrombosis Research|December 12, 2001
Ischemic stroke among inpatients with preceding inflammatory responseH Tohgi, H Takahashi, K Tamura, et al.
Neuroscience Letters|August 14, 1990
Effect of a synthetic norepinephrine precursor, L-threo-3,4- dihydroxyphenylserine on the total norepinephrine concentration in the cerebrospinal fluid of parkinsonian patientsH Tohgi, T Abe, S Takahashi, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 3, 1999
The cerebrospinal fluid oxidized NO metabolites, nitrite and nitrate, in Alzheimer's disease and vascular dementia of Binswanger type and multiple small infarct typeH Tohgi, T Abe, K Yamazaki, et al.
Neuroscience Letters|June 16, 1995
Effects of the catechol-O-methyltransferase inhibitor tolcapone in Parkinson's disease: correlations between concentrations of dopaminergic substances in the plasma and cerebrospinal fluid and clinical improvementH Tohgi, T Abe, K Yamazaki, et al.
European Neurology|January 1, 1991
The risk of cerebral infarction in non-valvular atrial fibrillation: effects of age, hypertension and antihypertensive treatmentH Tohgi, T Tajima, T Konno, et al.
Muscle & Nerve|February 1, 1997
Effects of CTG trinucleotide repeat expansion in leukocytes on quantitative muscle histopathology in myotonic dystrophyH Tohgi, K Utsugisawa, A Kawamorita, et al.
Neuroscience Letters|March 17, 1999
Increase in oxidized NO products and reduction in oxidized glutathione in cerebrospinal fluid from patients with sporadic form of amyotrophic lateral sclerosisH Tohgi, T Abe, K Yamazaki, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1985
[Vascular dementia--pathology and etiology]H Tohgi, K Sasaki, K Chiba, et al.
Pageof 18